31 December 1969
Comparative assessment of 200/0.5 HAES 6% and Gelafundin in the treatment of hypovolaemia in post-coronary bypass patientsBeata Dytkowska, Zbigniew Karwacki, Janina Suchorzewska, Maria Wujtewicz
Med Sci Monit 1998; 4(6): CR1000-1003 :: ID: 451758
40 patients after operations of coronary bypass in extracorporeal circulation were examined in order to evaluate usefulness of 200/0.5 HAES 6% and Gelafundin. The patients were divided into 2 groups, depending on received drug (group I - HAES, group 2 - Gelafundin). A single dose of up to 15 ml/kg b. m. of colloids was given to patients with diagnosed symptoms of hypovolaemia, haematocrit values over 30%. The following parameters were investigated: systolic, diastolic, mean arterial blood pressure, measured directly, as well as central venous pressure (CVP). The measurements were taken before the onset of infusion, as well as in 15, 30, 45, 60 minute of infusion and 15, 30 minutes after its completion. Biochemical parameters such as haemoglobin, haematocrit, number of platelets, albumin concentration, osmolality and selected blood clotting parameters were investigated before as well as 30 minutes after administration of the drugs. At the end of drug infusion, both groups demonstrated statistically significant increase of systolic and mean arterial blood pressure as well as central venous pressure. No significant effect of administered colloids upon biochemical parameters was
observed. Both HAES and Gelafundin were well tolerated by the patients. No allergic reactions were observed either during infusion or after its completion.
key words: coronary bypass • postoperative treatment • hypovolaemia
Keywords: coronary bypass, postoperative treatment, hypovolaemia
This Week Editorial
20 September 2021 : EditorialEditorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19
Med Sci Monit 2021; 27:e934766
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
24 Sep 2021 : Clinical ResearchA Single-Center Study of a Resin Inlay Dental Implant-Fixed Prosthesis for Closing Proximal Contact Loss in...
Med Sci Monit In Press; DOI: 10.12659/MSM.933809
24 Sep 2021 : Database AnalysisRelationships Between Obstructive Sleep Apnea and Cardiovascular Disease: A Bibliometric Analysis (2010-2021)
Med Sci Monit In Press; DOI: 10.12659/MSM.933448
24 Sep 2021 : Database AnalysisA Statistical Prediction Model for Survival After Kidney Transplantation from Deceased Donors
Med Sci Monit In Press; DOI: 10.12659/MSM.933559
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700